BioSpace News Archive

ClinOne is expanding its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect™ patient portal platform.

Phenomenex Inc., a global leader in the research, design and manufacturing of advanced technologies for the separation sciences, introduces Strata® PFAS, a new novel type of solid phase extraction (SPE) cartridge for extracting per- and polyfluorinated substances (PFAS) from water.

Ariadne Labs today released an Evidence Brief titled “Protecting Health Care Workers in South Korea During the COVID-19 Pandemic.”

The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.

NORD’s COVID-19 Premium & Medical Relief Program assists eligible rare disease patients facing financial challenges with out of pocket costs of health insurance premiums and limited medical assistance

Legend Biotech Corporation (“Legend”), a global clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies, announced today that Legend and Noile-Immune Biotech, Inc. (“Noile-Immune”), a biotechnology company focusing on the development of innovative cancer immunotherapies, have entered into a license agreement whereby Legend will have the right to develop CAR-T and/or TCR-T cell therapies

On May 14, 2020 Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services, will be participating in and sponsoring a PharmaVOICE virtual panel event.

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced it will be offering COVID-19 testing for nursing homes in the state of Mecklenburg-Western Pomerania, Germany - the location of the Company’s headquarters.

Neocis, Inc., the leader and innovator in dental implant surgery using advanced robotics, today announced a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new component for use with Yomi

Vir Biotechnology, Inc., a clinical-stage immunology company focused on treating and preventing serious infectious diseases, provided a corporate update and reported financial results for the first quarter ended March 31, 2020.